The Controlled Substances Therapeutic Research Act in the state of Washington.
In March 1979, the Governor of the State of Washington signed legislation establishing a THC/marihuana research program within the Washington State Board of Pharmacy. By November 1980, approximately 80 physicians had enrolled more than 400 patients on the chemotherapy protocol which randomly assigned subjects to receive either THC and prochlorperazine or THC and placebo. This report describes the process of implementing the legislation, the administrative and clinical roles of project personnel, and the design of three currently operating protocols.
D000970:Antineoplastic Agents / Q000009:adverse effects; D002188:Cannabis; D013759:Dronabinol / Q000627:therapeutic use; D006801:Humans; D007880:Legislation, Drug; D011346:Prochlorperazine / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration; D014861:Washington
D000970:Antineoplastic Agents; D013759:Dronabinol; D011346:Prochlorperazine